PRASHAD Scheme | Prime Minister Launches Full Delhi-Meerut RRTS Corridor | Biopharma Shakti

Posted on

Governance

In News

Union Civil Aviation Minister announced plans to enhance pilgrimage tourism in Andhra Pradesh under the PRASHAD scheme.

Pilgrimage Rejuvenation and Spiritual Augmentation Drive (PRASAD) Scheme

Launched in – 2014–2015
Financing – Central Sector Scheme
Implementation – Ministry of Tourism
Objective- It focuses on developing and identifying pilgrimage sites across India to enrich the religious tourism experience.
Significance – It improved infrastructure in tourism areas—roads, transport, sanitation, and utilities—and enhanced both residents’ quality of life and the overall experience for tourists.

Economy

News

The Prime Minister inaugurated India’s first Namo Bharat Regional Rapid Transit System (RRTS) and dedicated the 82-km Delhi-Meerut Namo Bharat Corridor to the nation.

Namo Bharat

It is India’s first Regional Rail connecting key urban nodes across the National Capital Region via high-speed rail corridors (82-km long corridor).
It is a rail-based, high-speed, high-frequency and sustainable transit system with a design speed of 180 Kmph and an average speed of 100 Kmph which aims at bringing people and places closer to NCR.
Implementing agency – National Capital Region Transport Corporation (NCRTC).
Significance- Bharat will provide fast, safe, and comfortable regional commute and encourage more people to switch to public transport by way of seamless integration among public transit systems in the region.

Economy

Context

India announced a massive investment of ₹10,000 crore in the Union Budget 2026-27 for the biotechnology sector.

Biopharma Shakti

The aim is to focus on boosting the production of biologics and biosimilars through a new initiative called the Biopharma Shakti.
The initiative aligns with the aim of transforming India into a leading global biopharma industry and capturing 5% of the global biopharmaceutical market share.
The initiative is designed to support domestic development and manufacturing of high-value biopharmaceutical products and medicines, reduce import dependence, and enhance India’s competitiveness in global biologics supply chains.
Biopharma involves production, manufacturing, or extraction of therapies through biological organisms, such as human cells, fungi, or microbes.
Some examples of biopharmaceuticals include vaccines, antibody treatments, gene therapies, cell implants, modern insulin, and recombinant protein drugs.

Comments